23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.
from The Seattle Times The Seattle Times https://ift.tt/cqtXpeA
23andMe cuts 40% of its workforce and discontinues therapeutics division
Reviewed by Sudhir Malekar
on
November 13, 2024
Rating:
No comments: